Product Life Cycle Limits May Level Playing Field For Generics - TCI's DiCicco
Executive Summary
Legislation that would limit branded product life cycle management strategies could level the playing field for generic drug products, Technology Catalysts International President Richard DiCicco said at the International Generic Drug Forum Jan. 24 in Washington, D.C.
You may also be interested in...
ANDA User Fee Creation Is Among Top NAPM Legislative Issues For 2000
The National Association of Pharmaceutical Manufacturers will press for the creation of generic drug user fees during the second session of the 106th Congress.
ANDA User Fee Creation Is Among Top NAPM Legislative Issues For 2000
The National Association of Pharmaceutical Manufacturers will press for the creation of generic drug user fees during the second session of the 106th Congress.
Waxman/Hatch Debate Moves Forward: Generic Biologics Not Ruled Out
A generic approval process for biological product is being recognized as one item for consideration in reform of the Waxman/Hatch Act by the law's key sponsor in the Senate.